Absence of APOL1 Risk Variants Protects against HIV-Associated Nephropathy in the Ethiopian Population
Authors:
- Eynat KedemEKEynat Kedem
- Saharon RossetSRSaharon Rosset
- Yonas HaileselassieYHYonas Haileselassie
- Shay TzurSTShay Tzur
- Zipi Kra-OzZKZipi Kra-Oz
- Walter G. WasserWWWalter G. Wasser
- Yotam ShenharYSYotam Shenhar
- Eduardo ShaharESEduardo Shahar
- Gamal HassounGHGamal Hassoun
- Carcom MaorCMCarcom Maor
- Dawit WoldayDWDawit Wolday
- 3 October 2011
- journal article
- research article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 34 (5) , 452-459
Abstract
Background: Susceptibility to end-stage kidney disease (ESKD) among HIV-infected Americans of African ancestral heritage has been attributed to APOL1 genetic variation. We determined the frequency of the APOL1 G1 and G2 risk variants together with the prevalence of HIV-associated nephropathy (HIVAN) among individuals of Ethiopian ancestry to determine whether the kidney disease genetic risk is PanAfrican or restricted to West Africa, and can explain the previously reported low risk of HIVAN among Ethiopians. Methods: We studied a cohort of 338 HIV-infected individuals of Ethiopian ancestry treated in one Israeli and one Ethiopian center. We sought clinical evidence for HIVAN (serum creatinine >1.4 mg/dl or proteinuria >30 mg/dl in a spot urine sample). Genetic analyses included the genotyping of the APOL1 G1 and G2 variants, and a panel of 33 genomic ancestry-informative markers. Statistical analysis compared clinical and genetic indices for HIV-infected individuals of Ethiopian ancestry and overall Ethiopians to those reported for HIV-infected African-Americans, overall African-Americans, West Africans and non-Africans. Findings: Three (0.8%) of 338 HIV-infected patients of Ethiopian ancestry showed clinical criteria compatible with renal impairment. Two of these 3 patients also have severe poorly controlled diabetes mellitus. The third nondiabetic patient underwent renal biopsy which ruled out HIVAN. This absence of clinically apparent HIVAN was significantly different from that reported for African-Americans. The APOL1 G1 and G2 risk variants were found, respectively, in 0 and 2 (heterozygote state) of the 338 HIV-infected individuals. Global ancestry and the frequencies of the APOL1 G1 and G2 variants are not statistically different from their frequencies in the general Ethiopian population, but are significantly and dramatically lower than those observed among HIV-infected African-Americans, African-Americans and West Africans. Interpretation: The coinciding absence of HIVAN and the APOL1 risk variants among HIV-infected individuals of Ethiopian ancestry support a Western rather than Pan-African ancestry risk for ESKD, and can readily explain the lack of HIVAN among individuals of Ethiopian ancestry.Keywords
This publication has 39 references indexed in Scilit:
- A map of human genome variation from population-scale sequencingNature, 2010
- Ancestry and Disease in the Age of Genomic MedicineNew England Journal of Medicine, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- The genome-wide structure of the Jewish peopleNature, 2010
- The Treatment of HIV-Associated NephropathyAdvances in Chronic Kidney Disease, 2010
- Controversies in the pathogenesis of HIV-associated renal diseasesNature Reviews Nephrology, 2009
- The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapyKidney International, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008
- Estimation of individual admixture: Analytical and study design considerationsGenetic Epidemiology, 2005